Breaking Down Elis SA Financial Health: Key Insights for Investors

FR | Industrials | Specialty Business Services | EURONEXT

Elis SA (ELIS.PA) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Elis SA's recent results demand attention: with 2024 revenue at €4,573.7m (up 6.1% year‑on‑year, organic growth 5.2%) and H1 2025 revenue of €2,343.1m (+4.3% y/y, organic ≈4%), the group paired top‑line resilience-driven by hospitality recovery, pricing effects and strategic acquisitions-with improving profitability (adjusted EBITDA €1,609.8m in 2024, +9.2%, margin 35.2%; H1 2025 adjusted EBITDA €813.8m, margin 34.7%) and a net income surge to €337.8m in 2024 (+29%); balance‑sheet metrics show net financial debt of €3,038.0m at Dec‑2024 with leverage falling to 1.85x (from 2.04x), equity of €3,598.2m and maintained investment‑grade ratings (S&P BBB‑, Moody's Baa3), while liquidity signals include H1 2025 free cash flow of €31m and average payment time improving to 52 days; valuation and shareholder returns are supported by a consensus €28.79 12‑month price target (≈12.9% upside) and ROE of 9.4% at Dec‑2024, but investors should weigh currency headwinds (notably a 13.2% negative impact in Latin America), regulatory and competitive risks, and the company's planned bolt‑on acquisition envelope (€50-150m p.a.) alongside ambitions to generate ~€1.5bn cumulative free cash flow between 2025-2028

Elis SA (ELIS.PA) Revenue Analysis

Elis reported consolidated revenue of €4,573.7 million in 2024, a 6.1% increase vs. 2023, with organic growth of 5.2%. In H1 2025 revenue reached €2,343.1 million, up 4.3% year‑on‑year, with organic growth adjusted for calendar effects of ~4% in the period. Recovery in hospitality activity (notably in France and Southern Europe) and continued M&A in Spain, Germany and Switzerland contributed to the top‑line momentum. Pricing effects-largely to offset wage inflation-supported revenue across geographies while commercial momentum produced numerous new contracts and expanded service scope despite a challenging European macro environment.
  • 2024 total revenue: €4,573.7m (+6.1% YoY; organic +5.2%)
  • H1 2025 revenue: €2,343.1m (+4.3% YoY; organic ≈ +4% adjusted for calendar)
  • Key sector dynamics: Hospitality recovery (Q2 2025) - France & Southern Europe
  • M&A: Strategic bolt‑ons in Spain, Germany, Switzerland to densify network and add cross‑sell opportunities
  • Pricing: Favorable pricing across regions to mitigate wage inflation impact
  • Commercial activity: New contracts and expanded service offerings sustaining recurring revenue
Metric Period Value YoY Growth Organic Growth
Consolidated Revenue FY 2024 €4,573.7m +6.1% +5.2%
Consolidated Revenue H1 2025 €2,343.1m +4.3% ≈ +4.0% (calendar‑adjusted)
Geographic drivers Q2 2025 France / Southern Europe Hospitality recovery -
M&A contribution 2024-H1 2025 Spain, Germany, Switzerland Incremental network density Supportive to reported growth
Mission Statement, Vision, & Core Values (2026) of Elis SA.

Elis SA (ELIS.PA) Profitability Metrics

Elis SA's recent results show improving margins and rising net income driven by operational efficiency and disciplined cost management.

  • Adjusted EBITDA 2024: €1,609.8 million, +9.2% year‑on‑year; margin 35.2%, +100 bps.
  • Adjusted EBITDA H1 2025: €813.8 million, +5.1% year‑on‑year; margin 34.7%.
  • Adjusted EBIT margin 2024: 16.0%, +20 bps year‑on‑year.
  • Net income 2024: €337.8 million, +29% year‑on‑year.
  • Headline net income per share 2024: €1.89, +1.3% year‑on‑year.
Metric 2023 2024 Change (YoY) H1 2024 H1 2025 Change (H1 YoY)
Adjusted EBITDA (€m) 1,474.0 1,609.8 +9.2% 774.6 813.8 +5.1%
Adjusted EBITDA margin 34.2% 35.2% +100 bps 33.9% 34.7% +80 bps
Adjusted EBIT margin 15.8% 16.0% +20 bps - - -
Net income (€m) 261.9 337.8 +29.0% - - -
Headline net income per share (€) 1.87 1.89 +1.3% - - -

The trajectory in adjusted EBITDA and EBIT margins corroborates Elis SA's strategic emphasis on operational efficiency and cost control; these improvements underpin the stronger net income performance and per‑share earnings. For additional context on investor interest and ownership trends, see Exploring Elis SA Investor Profile: Who's Buying and Why?

Elis SA (ELIS.PA) - Debt vs. Equity Structure

Elis SA's capital structure at year-end 2024 shows a deliberate balance between debt funding and shareholder equity, supporting ongoing expansion while keeping leverage at manageable levels. Key standalone metrics and credit assessments highlight both flexibility and areas to monitor for investors.
Metric Value (EUR or ratio) Comment
Net financial debt (31/12/2024) €3,038.0 million Includes leases and cash adjustments
Equity attributable to owners (31/12/2024) €3,598.2 million Core book equity supporting operations
Financial leverage ratio (Net debt / EBITDA) 1.85x (2024) - down from 2.04x (2023) Trend indicates deleveraging
Expected financial leverage (31/12/2025) ~1.75x Management guidance: ~0.1x reduction
Debt-to-equity ratio 1.19 Moderate leverage relative to equity base
S&P Global Ratings BBB- Investment-grade
Moody's Baa3 Investment-grade
  • Strengths: Investment-grade ratings (S&P BBB-, Moody's Baa3) provide lower funding costs and market access.
  • Strengths: Net debt of €3,038.0m is supported by €3,598.2m in equity, yielding a balanced debt-to-equity ratio of 1.19.
  • Trend: Financial leverage fell from 2.04x to 1.85x in 2024 - management targets ~1.75x by end-2025.
  • Risks: Continued M&A or capex without commensurate cash flow improvement could stall the planned deleveraging.
  • Risks: Macroeconomic shocks or margin pressure could increase leverage ratios and test covenant headroom.
Operational and strategic financing implications:
  • Balanced capital structure supports growth initiatives while preserving financial flexibility for acquisitions and reinvestment.
  • Investment-grade ratings reduce marginal borrowing costs, enabling competitive financing for rollout and efficiency projects.
  • Planned reduction in financial leverage (~0.1x by 2025) suggests focus on cash generation and selective capital allocation.
For additional context on Elis SA's broader strategic orientation and long-term priorities, see: Mission Statement, Vision, & Core Values (2026) of Elis SA.

Elis SA (ELIS.PA) Liquidity and Solvency

Elis SA's liquidity and solvency profile through mid-2025 shows continued operational cash generation alongside modestly higher financial costs and a slight uptick in leverage. Key cash-flow and capital-structure datapoints illustrate how the group balances working capital, refinancing costs and shareholder returns.
  • Free cash flow: €31 million reported in H1 2025, consistent with the group's expected yearly cash-flow sequence.
  • Net interest paid: €78.9 million in 2024, up €8.4 million vs. 2023 due to higher-cost refinancings executed recently.
  • Average supplier payment time improved to 52 days at 31 Dec 2024, down from 55 days a year earlier, reflecting tighter payables management.
  • Financial leverage: 1.92x at 30 Jun 2025 vs. 1.85x at 31 Dec 2024, indicating a slight increase in net debt relative to EBITDA.
  • Cash allocation policy: explicit focus on enhancing shareholder returns through dividends and share buybacks while preserving investment capacity.
Metric Most Recent Figure Prior/Comparison
Free Cash Flow (H1) €31.0m (H1 2025) In line with expected yearly pattern
Net Interest Paid €78.9m (2024) +€8.4m vs 2023
Average Payment Time (Days) 52 days (31 Dec 2024) 55 days (31 Dec 2023)
Financial Leverage (Net Debt / EBITDA) 1.92x (30 Jun 2025) 1.85x (31 Dec 2024)
Shareholder Return Policy Dividends & share buybacks Ongoing cash-allocation emphasis
  • Liquidity coverage: steady operating cash conversion and improved payables days support near-term liquidity needs despite higher interest outlays.
  • Solvency posture: leverage below typical covenant thresholds for industrial/service groups, giving room for strategic investment while executing shareholder returns.
  • Refinancing impact: elevated 2024 interest cash outflow highlights sensitivity to debt repricing; monitoring coupon and maturity profile remains important.
For further context on ownership and investor behavior related to Elis SA, see: Exploring Elis SA Investor Profile: Who's Buying and Why?

Elis SA (ELIS.PA) - Valuation Analysis

Elis SA's market valuation reflects analyst confidence, operational profitability and shareholder-friendly capital deployment. Key signals point to a constructive equity case supported by earnings momentum, return metrics and active balance sheet management.
  • Analyst consensus: Rated 'Strong Buy' with a 12‑month average price target of €28.79, implying a potential upside of 12.88% from current levels.
  • Return on equity (ROE): 9.4% as of December 2024, indicating effective use of shareholders' funds versus historical peers.
  • Earnings per share (EPS): H1 2025 EPS of €0.85, up 3.0% year‑over‑year, driven by share cancellations and a 2.6% increase in headline net income.
  • Capital allocation: Disciplined program including share buybacks and progressive dividend increases, bolstering per‑share metrics and investor returns.
Metric Value Period / Note
Analyst Rating Strong Buy Consensus
12‑month Price Target €28.79 Average target
Implied Upside 12.88% From current price
ROE 9.4% As of Dec 2024
EPS €0.85 H1 2025, +3.0% YoY
Headline Net Income Change +2.6% H1 2025 YoY
Capital Actions Share buybacks & dividend increases Ongoing
Valuation drivers include steady organic revenue and margin control, EPS accretion from share cancellations, and a clear capital return policy that supports multiple expansion. For strategic context on corporate priorities that underpin valuation, see Mission Statement, Vision, & Core Values (2026) of Elis SA.

Elis SA (ELIS.PA) Risk Factors

Elis SA operates a capital- and service-intensive business across Europe and Latin America. Several clear risk vectors can materially influence near- and medium-term financial performance, cash flow generation and valuation multiples.

  • Geographic expansion & regulatory shifts: expansion into new countries exposes Elis to local labor, tax and compliance regimes that can increase operating costs and capital requirements.
  • Currency exposure: Elis reported a 13.2% negative currency impact in H1 2025 in Latin America, underscoring FX volatility as a tangible earnings headwind.
  • Cyclicality of end markets: demand from hospitality, healthcare and workwear is sensitive to economic cycles-downturns reduce linens rental volumes and service frequency.
  • Competitive pressure: multiple regional and local competitors require continual investment in pricing, service innovation and cost-efficiency to protect margins.
  • Supply chain disruptions: interruptions to linen, textile or equipment supply - or logistics bottlenecks - can raise replacement costs and delay service rollouts.
  • Environmental & sustainability regulation: tightening rules and customer ESG expectations drive CAPEX for water, energy and chemical management and can increase operating costs.

Quantifying potential impacts helps investors frame downside risk. The illustrative sensitivity table below models revenue and EBITDA effects under a set of plausible negative scenarios, using the 13.2% FX shock as a reference point for Latin American exposure.

Scenario Revenue change vs base EBITDA change vs base Notes / Key drivers
13.2% FX shock (Latin America) -5% (group-level, illustrative) -7% (margin squeeze from conversion and hedging costs) Reflects observed H1 2025 negative currency impact concentrated in LATAM
Moderate economic downturn -8% -10% (operating leverage) Lower volumes in hospitality & workwear; partial pricing pass-through limits
Supply chain shock (6 months) -3% (lost sales & delayed installs) -5% (higher freight and substitute sourcing costs) Temporary service disruptions and spot-price inflation for textiles/equipment
Accelerated ESG capex requirement 0% (revenues stable) -4% (higher depreciation/opex in short term) CAPEX for water/energy upgrades and compliance; payback over multiple years

Key operational and financial metrics investors should monitor regularly:

  • Geographic revenue split and country-level margins - to gauge concentration and FX sensitivity.
  • Hedging policy and realized FX P&L - frequency and size of currency impacts (e.g., the 13.2% LATAM FX hit in H1 2025).
  • Order intake / contract renewals in hospitality, healthcare and corporate segments - early signals of demand shifts.
  • Working capital intensity and capex trajectory - indicators of cash flow resilience under stress.
  • Supply chain lead times, supplier concentration and contingency plans - to assess disruption risk.

Data-driven monitoring and scenario planning are essential to value Elis SA's growth opportunities while managing these material risks. For investor context and shareholder composition, see: Exploring Elis SA Investor Profile: Who's Buying and Why?

Elis SA (ELIS.PA) - Growth Opportunities

Elis SA is executing a multi-pronged growth strategy that combines disciplined organic expansion, targeted bolt-on M&A, geographic diversification into high-growth markets, and sustainability-driven service innovation. The plan is backed by explicit financial targets and capital deployment programs designed to convert operational strength into shareholder value.
  • Bolt-on acquisitions: annual envelope of €50-€150 million to strengthen service offerings and market presence.
  • Free cash flow target: ~€1.5 billion cumulative between 2025 and 2028 (≈€375 million/year on average over the period).
  • Geographic expansion: push into high-growth regions (example highlighted: Malaysia) to capture faster-growing contract wins and diversify end‑market exposure.
  • Sustainability positioning: circular economy model and eco-friendly services to meet rising corporate and regulatory demand for green solutions.
  • Shareholder returns: ongoing share buyback program and progressive dividend policy aimed at enhancing shareholder value and supporting equity demand.
The combined effects of these initiatives can be summarized in the following practical metrics and deployment plan:
Metric / Program Target / Range Timing Investor Implication
Bolt-on M&A envelope €50-€150 million per year Ongoing (annual) Accretive scale gains; faster entry into adjacent services and regions
Cumulative free cash flow €1.5 billion 2025-2028 Funds growth capex, M&A, buybacks, and dividends
Implied avg. FCF per year (2025-2028) ≈€375 million 2025-2028 Supports multi-year capital allocation flexibility
Geographic priority High-growth markets (e.g., Malaysia) Near-term expansion focus Higher organic growth potential; diversification
Sustainability / circular model Ongoing investment & service rollout Medium-to-long term Demand capture from ESG-driven customers; potential cost savings
Shareholder return mechanisms Buybacks + dividend increases Ongoing Enhances EPS and attracts income/total-return investors
Operational and capital-allocation discipline will determine how effectively Elis converts the planned €1.5 billion FCF into durable growth. Key near-term indicators to monitor include acquisition execution at the €50-€150 million cadence, FCF realization versus the €375 million annualized benchmark, and traction in targeted high-growth geographies. For investor background and ownership trends, see: Exploring Elis SA Investor Profile: Who's Buying and Why?

DCF model

Elis SA (ELIS.PA) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.